Drugs Used in Diarrhea

(Note: For PDF File Swipe To The End Of Article)

Introduction

Diarrhea is one of the most common gastrointestinal disorders encountered in clinical practice and is characterized by the passage of loose, watery, or frequent stools. It may occur as an acute illness lasting less than two weeks, persistent diarrhea lasting between two and four weeks, or chronic diarrhea that continues for more than four weeks. Although many episodes are self-limiting, diarrhea remains a major cause of morbidity and mortality worldwide, particularly among children, elderly individuals, and immunocompromised patients. Excessive loss of water and electrolytes can rapidly lead to dehydration, electrolyte imbalance, hypovolemic shock, renal impairment, and death if not managed promptly.

The treatment of diarrhea involves more than simply reducing stool frequency. Effective management focuses on correcting dehydration, replacing electrolyte losses, treating the underlying cause whenever possible, relieving symptoms, and preventing complications. Drug therapy should always be selected according to the etiology, severity of illness, age of the patient, and associated clinical features. While oral rehydration therapy remains the cornerstone of treatment, several pharmacological agents play an important role in reducing symptoms, shortening disease duration, and treating specific infectious causes.

The major categories of drugs used in diarrhea include oral rehydration solutions, antimotility agents, adsorbents, antisecretory drugs, probiotics, antimicrobial agents, zinc supplements, and medications used for chronic inflammatory or functional bowel diseases. Understanding the mechanism of action, indications, contraindications, adverse effects, and limitations of these medications is essential for rational prescribing and safe patient care.

---

Physiology of Fluid Absorption and Secretion in the Intestine

To understand how antidiarrheal drugs work, it is important to understand the normal physiology of intestinal fluid transport.

The small intestine receives approximately 8–10 liters of fluid daily from ingested food, saliva, gastric secretions, pancreatic secretions, bile, and intestinal secretions. Under normal conditions, nearly all of this fluid is reabsorbed before reaching the colon, leaving only about 100–200 mL to be excreted in the feces.

Water absorption occurs passively and follows the movement of sodium across intestinal epithelial cells. Sodium absorption occurs through multiple transport systems, including sodium-glucose cotransporters, sodium-hydrogen exchangers, and epithelial sodium channels. Chloride ions and water follow sodium absorption, maintaining fluid balance.

Diarrhea develops when this balance is disturbed. The mechanisms include:

• Increased intestinal secretion of electrolytes and water
• Reduced absorption of sodium and water
• Increased intestinal motility
• Osmotic retention of water within the intestinal lumen
• Inflammation causing exudation of proteins, mucus, and blood

Different classes of antidiarrheal drugs target one or more of these pathological mechanisms.

---

Classification of Drugs Used in Diarrhea

The pharmacological agents used in diarrhea can be classified into the following major groups:

1. Fluid and Electrolyte Replacement

• Oral Rehydration Solution (ORS)
• Intravenous fluids

2. Antimotility Drugs

• Loperamide
• Diphenoxylate with atropine

3. Opioid Derivatives

• Codeine
• Tincture of opium (rarely used)

4. Adsorbents

• Kaolin
• Pectin
• Activated charcoal
• Attapulgite

5. Antisecretory Drugs

• Racecadotril
• Bismuth subsalicylate

6. Probiotics

• Lactobacillus species
• Saccharomyces boulardii
• Bifidobacterium species

7. Antimicrobial Drugs

• Ciprofloxacin
• Azithromycin
• Rifaximin
• Metronidazole
• Vancomycin
• Fidaxomicin
• Tinidazole
• Nitazoxanide

8. Zinc Supplements

• Zinc sulfate

9. Drugs for Chronic Diarrhea

• Mesalamine
• Sulfasalazine
• Corticosteroids
• Immunosuppressants
• Biologic agents

Each group has specific indications and should be prescribed only after evaluating the cause of diarrhea.

---

Oral Rehydration Therapy (ORT)

Oral rehydration therapy is the single most effective and life-saving treatment for acute diarrhea. It prevents dehydration and corrects electrolyte imbalance without directly affecting stool frequency. Millions of lives have been saved worldwide through the widespread use of oral rehydration solution.

ORS works because sodium and glucose are absorbed together through the sodium-glucose cotransporter (SGLT-1) located in the intestinal mucosa. Even during severe infectious diarrhea, this transport mechanism remains functional. As glucose and sodium are absorbed, water follows by osmosis, restoring hydration.

The World Health Organization recommends a low-osmolarity oral rehydration solution containing:

• Sodium
• Glucose
• Potassium
• Chloride
• Citrate

The reduced osmolarity formula decreases stool volume, vomiting, and the need for intravenous fluids compared with the older formulation.

Advantages of ORS include:

• Prevents dehydration
• Corrects electrolyte imbalance
• Inexpensive
• Easy to prepare
• Safe for children and adults
• Reduces mortality significantly

ORS should be administered after every loose stool, with the amount adjusted according to the patient's age and degree of dehydration.

In severe dehydration, persistent vomiting, altered consciousness, or shock, intravenous fluid therapy using Ringer's lactate or normal saline becomes necessary.

---

Antimotility Drugs

Antimotility drugs decrease intestinal peristalsis, allowing more time for water and electrolyte absorption. These agents provide rapid symptomatic relief and are commonly used for acute non-infectious diarrhea and traveler's diarrhea.

They should not be used indiscriminately because slowing intestinal motility in invasive bacterial infections may prolong the disease or increase the risk of complications.

These drugs are generally contraindicated in:

• Bloody diarrhea
• High fever
• Suspected dysentery
• Clostridioides difficile infection
• Acute ulcerative colitis
• Toxic megacolon
• Young children without medical supervision

Appropriate patient selection is essential before initiating antimotility therapy.

Loperamide

Loperamide is the most commonly prescribed antimotility drug for the symptomatic treatment of acute and chronic diarrhea. It is a synthetic opioid derivative that acts primarily on the μ-opioid receptors located in the myenteric plexus of the intestinal wall. Unlike morphine and other opioid analgesics, loperamide has minimal penetration into the central nervous system because it is actively pumped out of the brain by P-glycoprotein transporters. Therefore, when used at recommended doses, it produces little or no analgesic or euphoric effect and has a very low potential for abuse.

Loperamide decreases the propulsive activity of the intestine by inhibiting the release of acetylcholine and prostaglandins from enteric neurons. This slows intestinal transit time, allowing more water and electrolytes to be absorbed from the intestinal lumen. It also increases the tone of the anal sphincter, which helps reduce fecal urgency and episodes of incontinence. In addition, loperamide reduces intestinal secretion to some extent, further contributing to its antidiarrheal action.

Loperamide is indicated for acute nonspecific diarrhea, traveler's diarrhea without fever or bloody stools, chronic diarrhea associated with inflammatory bowel disease, irritable bowel syndrome with diarrhea (IBS-D), and diarrhea occurring after intestinal resection or ileostomy. It provides rapid symptomatic relief by reducing stool frequency, improving stool consistency, and decreasing abdominal cramping.

The usual adult dose is 4 mg initially, followed by 2 mg after each loose stool. The maximum recommended daily dose is generally 16 mg under medical supervision, although lower limits apply for over-the-counter use. Patients should be advised not to exceed the recommended dose because high doses can lead to serious cardiac toxicity, including QT interval prolongation, ventricular arrhythmias, torsades de pointes, and sudden cardiac death.

Common adverse effects include constipation, abdominal discomfort, nausea, dizziness, abdominal distension, dry mouth, and mild drowsiness. Severe constipation or paralytic ileus may occur in susceptible individuals. Very rarely, toxic megacolon has been reported, particularly in patients with inflammatory bowel disease.

Loperamide should never be used in patients with bloody diarrhea, high-grade fever, pseudomembranous colitis caused by Clostridioides difficile, acute ulcerative colitis during severe attacks, bacterial dysentery caused by invasive organisms such as Shigella, Salmonella, or enteroinvasive Escherichia coli, or in children younger than the recommended age without medical advice. In these conditions, suppression of intestinal motility may delay elimination of pathogens and worsen the disease.

Drug interactions may occur with medications that inhibit P-glycoprotein or CYP3A4 enzymes, increasing plasma concentrations of loperamide. Careful monitoring is therefore necessary in patients receiving such medications.

---

Diphenoxylate with Atropine

Diphenoxylate is another opioid derivative used as an antidiarrheal agent. It is structurally related to meperidine and acts by stimulating μ-opioid receptors in the gastrointestinal tract. Activation of these receptors suppresses intestinal motility, prolongs transit time, and enhances absorption of water and electrolytes.

Unlike loperamide, diphenoxylate can cross the blood-brain barrier at high doses and may produce central opioid effects such as sedation, respiratory depression, and euphoria. To discourage intentional misuse and overdose, diphenoxylate is combined with a subtherapeutic dose of atropine. At therapeutic doses, atropine has little effect on diarrhea but produces unpleasant anticholinergic symptoms such as dry mouth, blurred vision, tachycardia, and flushing if excessive tablets are taken.

Diphenoxylate with atropine is indicated for the symptomatic management of acute noninfectious diarrhea and chronic diarrhea when other supportive measures alone are insufficient. It is generally considered a second-line agent because loperamide has a better safety profile and fewer central nervous system effects.

The usual adult dosage is two tablets (each containing diphenoxylate 2.5 mg with atropine 0.025 mg) four times daily initially. The dose is gradually reduced as symptoms improve. Long-term therapy should be supervised by a physician.

Common adverse effects include constipation, nausea, abdominal bloating, drowsiness, dizziness, dry mouth, urinary retention, blurred vision, tachycardia, and headache. Excessive doses may produce opioid toxicity, including respiratory depression and coma, especially in children.

Diphenoxylate should not be administered to children younger than six years because of the increased risk of severe respiratory depression and central nervous system toxicity. It is also contraindicated in patients with obstructive jaundice, severe ulcerative colitis with toxic megacolon, pseudomembranous colitis, bacterial enterocolitis caused by invasive pathogens, and acute dysentery associated with high fever or blood in the stool.

Patients should be advised to maintain adequate hydration while taking diphenoxylate and to discontinue the medication if abdominal distension, persistent fever, worsening diarrhea, or severe constipation develops. Long-term or inappropriate use should be avoided because of the potential for dependence and adverse effects.

Opioid Antidiarrheal Drugs

Besides loperamide and diphenoxylate, certain opioid drugs have historically been used to manage severe diarrhea because of their ability to reduce intestinal motility and secretion. These agents are now used much less frequently due to the availability of safer alternatives and the risk of central nervous system effects, dependence, and respiratory depression.

The principal opioid drugs used for diarrhea include:

• Codeine phosphate
• Tincture of opium (Deodorized opium tincture)
• Paregoric (Camphorated tincture of opium, now rarely used)

These medications should only be used under strict medical supervision, especially in patients with chronic diarrhea that has not responded to standard therapy.

---

Codeine

Codeine is a naturally occurring opioid alkaloid that possesses analgesic, antitussive, and antidiarrheal properties. It acts by stimulating μ-opioid receptors in the enteric nervous system, resulting in reduced intestinal propulsive activity. This prolongs intestinal transit time, allowing greater absorption of water and electrolytes from the intestinal lumen.

In addition to decreasing intestinal motility, codeine also increases the tone of the anal sphincter, thereby reducing fecal urgency and improving stool consistency.

Codeine is occasionally used for chronic diarrhea associated with conditions such as:

• Diabetic autonomic neuropathy
• Short bowel syndrome
• Ileostomy-associated diarrhea
• Chronic radiation enteritis
• Palliative care for refractory diarrhea

Its use in acute infectious diarrhea is generally discouraged because slowing intestinal transit may delay elimination of infectious organisms and increase the risk of complications.

Mechanism of Action

Codeine binds to μ-opioid receptors present in the intestinal wall. Activation of these receptors produces:

• Decreased acetylcholine release
• Reduced intestinal peristalsis
• Increased segmentation of intestinal contractions
• Prolonged transit time
• Enhanced absorption of water and electrolytes
• Reduced intestinal secretion

Therapeutic Uses

Codeine may be considered in selected patients with:

• Chronic severe diarrhea
• High-output ileostomy
• Short bowel syndrome
• Chronic radiation-induced diarrhea
• Palliative care patients

Adverse Effects

Because codeine enters the central nervous system, its adverse effects are more significant than those of loperamide.

Common adverse effects include:

• Constipation
• Drowsiness
• Sedation
• Nausea
• Vomiting
• Dizziness
• Dry mouth
• Respiratory depression (high doses)
• Dependence with prolonged use
• Physical tolerance

Contraindications

Codeine should not be used in:

• Acute dysentery
• Bloody diarrhea
• Severe respiratory disease
• Acute asthma
• Head injury
• Children after tonsillectomy or adenoidectomy
• Pregnancy near delivery
• Patients with opioid dependence

Because of its abuse potential, codeine is no longer considered a first-line antidiarrheal drug.

---

Tincture of Opium

Tincture of opium is a concentrated preparation containing morphine and several naturally occurring opioid alkaloids. It has a potent inhibitory effect on gastrointestinal motility and intestinal secretion.

Although rarely prescribed today, tincture of opium remains useful for selected patients with severe chronic diarrhea that does not respond to conventional treatment.

Mechanism of Action

The morphine present in tincture of opium activates μ-opioid receptors throughout the gastrointestinal tract.

This results in:

• Marked reduction in intestinal motility
• Increased intestinal transit time
• Increased absorption of fluids
• Reduced intestinal secretion
• Increased anal sphincter tone

Clinical Uses

Tincture of opium is reserved for:

• Severe refractory chronic diarrhea
• Short bowel syndrome
• High-output intestinal fistulas
• High-output ileostomy
• Palliative care

Adverse Effects

Its adverse effects resemble those of morphine and include:

• Severe constipation
• Sedation
• Respiratory depression
• Nausea
• Vomiting
• Urinary retention
• Hypotension
• Dependence
• Tolerance
• Withdrawal symptoms after prolonged use

Contraindications

It should be avoided in:

• Infectious diarrhea
• Respiratory depression
• Acute asthma
• Severe liver disease
• Head injury
• Paralytic ileus
• Pregnancy unless clearly indicated

Because of the significant risk of addiction and overdose, tincture of opium is prescribed only when safer medications have failed.

---

Adsorbent Antidiarrheal Drugs

Adsorbents are substances that bind toxins, bacteria, viruses, and excess fluid within the intestinal lumen. They provide symptomatic relief but do not eliminate the underlying cause of diarrhea.

These agents are considerably less effective than oral rehydration therapy and antimotility drugs. Their role has diminished over time because controlled clinical trials have demonstrated only modest benefits.

The major adsorbent drugs include:

• Kaolin
• Pectin
• Attapulgite
• Activated charcoal (selected situations)

Although these drugs may reduce stool consistency, they do not significantly shorten the duration of infectious diarrhea.

---

Kaolin and Pectin

Kaolin is a naturally occurring hydrated aluminum silicate clay, while pectin is a soluble plant polysaccharide obtained from fruits. These substances were traditionally combined as an oral suspension for the symptomatic treatment of mild diarrhea.

Kaolin adsorbs bacterial toxins and excess water within the intestinal lumen, while pectin helps absorb water and forms a protective coating over the intestinal mucosa.

Mechanism of Action

Kaolin and pectin act by:

• Adsorbing bacterial toxins
• Binding excess intestinal water
• Increasing stool consistency
• Protecting inflamed intestinal mucosa

Unlike opioid drugs, they do not affect intestinal motility.

Therapeutic Uses

Historically they were used for:

• Mild acute diarrhea
• Traveler's diarrhea
• Functional diarrhea

Today they are used much less frequently because evidence supporting their effectiveness is limited.

Adverse Effects

These drugs are generally well tolerated.

Possible adverse effects include:

• Constipation
• Abdominal fullness
• Reduced absorption of certain medications such as digoxin, tetracyclines, and quinolones when taken simultaneously

Patients should separate these medications from other oral drugs by at least two to three hours to minimize drug interactions.

Attapulgite

Attapulgite is a naturally occurring magnesium aluminum silicate clay that has long been used as an adsorbent antidiarrheal agent. It acts locally within the gastrointestinal tract and is not absorbed into the systemic circulation. Attapulgite works by binding bacteria, bacterial toxins, viruses, bile acids, and excess water in the intestinal lumen, thereby increasing stool consistency and reducing stool frequency.

Although it has been widely used in the past, current treatment guidelines generally do not recommend routine use because clinical studies have shown limited effectiveness compared with oral rehydration therapy and other evidence-based treatments. Nevertheless, it may still provide temporary symptomatic relief in mild cases of noninfectious diarrhea.

Mechanism of Action

Attapulgite exerts its effects through several local actions:

• Adsorbs bacterial toxins and microorganisms
• Binds excess water in the intestinal lumen
• Increases stool firmness
• Protects the intestinal mucosa
• Does not significantly alter intestinal motility
• Is not systemically absorbed

Therapeutic Uses

Attapulgite has been used for:

• Mild acute diarrhea
• Functional diarrhea
• Nonspecific diarrhea in adults

It should not be considered a substitute for oral rehydration therapy, especially in children or patients with dehydration.

Adverse Effects

Attapulgite is generally well tolerated because it is not absorbed from the gastrointestinal tract.

Possible adverse effects include:

• Constipation
• Abdominal discomfort
• Bloating
• Nausea

Drug Interactions

Attapulgite can adsorb several orally administered drugs and reduce their absorption.

Examples include:

• Tetracyclines
• Fluoroquinolones
• Digoxin
• Iron preparations
• Levothyroxine

These medications should be taken at least two to three hours before or after attapulgite.

Contraindications

Attapulgite should be avoided in:

• Severe infectious diarrhea
• Bloody diarrhea
• High fever
• Suspected intestinal obstruction
• Severe constipation

---

Activated Charcoal

Activated charcoal is a highly porous form of carbon with a very large surface area that enables it to adsorb numerous chemicals and toxins. Although it is primarily used in the emergency management of acute poisoning, it has occasionally been employed for certain diarrheal illnesses associated with toxin ingestion.

Its routine use in ordinary acute diarrhea is not recommended because evidence supporting its benefit is limited.

Mechanism of Action

Activated charcoal acts by:

• Adsorbing toxins
• Binding certain bacterial products
• Reducing absorption of harmful chemicals
• Preventing further intestinal absorption of toxins

It has little direct effect on intestinal secretion or motility.

Therapeutic Uses

Activated charcoal is mainly indicated for:

• Acute poisoning
• Selected toxin-mediated gastrointestinal illnesses

It has only a limited role in uncomplicated diarrhea.

Adverse Effects

Common adverse effects include:

• Black discoloration of stools
• Constipation
• Nausea
• Vomiting

Rare but serious complications include aspiration pneumonitis if administered to patients with impaired consciousness without airway protection.

Contraindications

Activated charcoal should not be administered in:

• Intestinal obstruction
• Paralytic ileus
• Gastrointestinal perforation
• Patients unable to protect their airway
• Corrosive acid or alkali poisoning

---

Antisecretory Drugs

Antisecretory drugs reduce the excessive secretion of water and electrolytes into the intestinal lumen without markedly affecting intestinal motility. They are particularly useful in secretory diarrhea and have a lower risk of causing constipation or toxic megacolon than antimotility agents.

The two most commonly used antisecretory drugs are:

• Racecadotril
• Bismuth subsalicylate

These drugs may be used alone or together with oral rehydration therapy depending on the clinical situation.

---

Racecadotril

Racecadotril is an intestinal antisecretory drug that has become increasingly popular for the treatment of acute diarrhea in both adults and children. Unlike loperamide, it does not significantly slow intestinal transit, thereby reducing the risk of bacterial retention and constipation.

Racecadotril is a prodrug that is converted in the body to thiorphan, an active metabolite that inhibits the enzyme enkephalinase.

Mechanism of Action

Enkephalinase normally breaks down endogenous enkephalins present in the intestinal mucosa.

By inhibiting this enzyme, racecadotril:

• Increases endogenous enkephalin levels
• Reduces intestinal secretion of water and electrolytes
• Decreases stool volume
• Does not significantly affect intestinal motility
• Does not cause significant constipation

Because intestinal transit remains relatively normal, pathogens continue to be eliminated from the bowel.

Therapeutic Uses

Racecadotril is indicated for:

• Acute watery diarrhea
• Acute gastroenteritis
• Pediatric diarrhea
• Adult acute diarrhea

It is always used together with oral rehydration therapy rather than as a replacement.

Advantages Over Loperamide

Compared with loperamide, racecadotril:

• Causes less constipation
• Produces minimal abdominal distension
• Does not significantly prolong intestinal transit
• Has a lower risk of rebound constipation
• May be safer in children under appropriate medical guidance

Adverse Effects

Racecadotril is generally very well tolerated.

Reported adverse effects include:

• Headache
• Nausea
• Mild abdominal pain
• Skin rash
• Vomiting
• Rare allergic reactions

Contraindications

Racecadotril should be avoided in:

• Known hypersensitivity
• Severe chronic diarrhea without diagnosis
• Patients with hereditary fructose intolerance (certain formulations)

Its safety during pregnancy and breastfeeding should be evaluated before use.

---

Bismuth Subsalicylate

Bismuth subsalicylate is a unique antidiarrheal drug possessing antisecretory, anti-inflammatory, antibacterial, and adsorbent properties. It is widely used for mild acute diarrhea, traveler's diarrhea, and gastrointestinal upset.

After oral administration, it is hydrolyzed into bismuth and salicylic acid. Both components contribute to its therapeutic effects.

Mechanism of Action

Bismuth subsalicylate acts through multiple mechanisms:

• Inhibits intestinal prostaglandin synthesis
• Reduces intestinal chloride secretion
• Decreases water loss into the bowel
• Binds bacterial toxins
• Exhibits antibacterial activity against several enteric pathogens
• Has activity against Helicobacter pylori when used as part of combination therapy
• Protects the gastrointestinal mucosa

These combined actions reduce stool frequency and improve stool consistency while helping control inflammation within the intestinal tract.

Therapeutic Uses of Bismuth Subsalicylate

Bismuth subsalicylate is widely used because of its broad spectrum of gastrointestinal actions. It provides symptomatic relief while also exerting mild antimicrobial effects against several enteric pathogens.

The major clinical indications include:

• Acute nonspecific diarrhea
• Traveler's diarrhea
• Prevention of traveler's diarrhea
• Food poisoning with mild symptoms
• Gastroenteritis
• Dyspepsia (indigestion)
• Heartburn
• Nausea
• Upset stomach
• Adjunctive therapy in Helicobacter pylori eradication regimens

For traveler's diarrhea, bismuth subsalicylate may be taken prophylactically for a limited period in adults traveling to high-risk regions, although it should not replace proper food and water precautions.

---

Adverse Effects of Bismuth Subsalicylate

Bismuth subsalicylate is generally safe when used for short periods.

Common adverse effects include:

• Black discoloration of the tongue
• Black stools
• Constipation
• Mild nausea
• Abdominal discomfort

The black discoloration of the stool and tongue is harmless and results from the formation of bismuth sulfide in the gastrointestinal tract.

Less common adverse effects include:

• Tinnitus (ringing in the ears)
• Salicylate toxicity with excessive doses
• Allergic reactions
• Vomiting
• Dizziness

Rare but serious adverse effects include:

• Bleeding tendencies due to salicylate
• Metabolic acidosis in severe overdose
• Neurotoxicity after prolonged excessive use

---

Contraindications of Bismuth Subsalicylate

Bismuth subsalicylate should be avoided in the following situations:

• Allergy to aspirin or salicylates
• Active gastrointestinal bleeding
• Bleeding disorders
• Severe renal impairment
• Children and adolescents recovering from viral infections because of the risk of Reye's syndrome
• Pregnancy, particularly during the third trimester
• Patients receiving anticoagulants unless advised by a physician

Caution is also advised in patients taking aspirin, warfarin, methotrexate, or other salicylate-containing medications because of the increased risk of bleeding.

---

Probiotics

Probiotics are live microorganisms that, when administered in adequate amounts, provide health benefits to the host. They help restore the normal intestinal microbial flora that may be disrupted by infections, antibiotics, or gastrointestinal diseases.

Probiotics are increasingly used as adjunctive therapy for acute infectious diarrhea, antibiotic-associated diarrhea, and certain chronic gastrointestinal disorders. They are not replacements for oral rehydration therapy but may reduce the duration and severity of illness.

The most commonly used probiotic organisms include:

• Lactobacillus species
• Saccharomyces boulardii
• Bifidobacterium species
• Streptococcus thermophilus
• Enterococcus species (selected preparations)

---

Mechanism of Action of Probiotics

Probiotics exert their beneficial effects through multiple mechanisms rather than a single pathway.

These include:

• Restoration of normal intestinal flora
• Competition with pathogenic bacteria for nutrients and adhesion sites
• Production of antimicrobial substances such as bacteriocins
• Reduction of intestinal pH through lactic acid production
• Enhancement of intestinal epithelial barrier function
• Stimulation of mucosal immunity
• Increased production of secretory IgA
• Modulation of inflammatory responses
• Inhibition of bacterial toxin production
• Promotion of epithelial healing

These combined effects shorten the duration of diarrhea and reduce recurrence in selected patients.

---

Lactobacillus

Lactobacillus species are among the most extensively studied probiotics in gastrointestinal medicine. They are normal inhabitants of the human gastrointestinal tract and contribute to maintaining microbial balance.

Therapeutic Uses

Lactobacillus preparations are commonly used in:

• Acute infectious diarrhea
• Rotavirus diarrhea in children
• Antibiotic-associated diarrhea
• Traveler's diarrhea
• Irritable bowel syndrome
• Prevention of recurrent Clostridioides difficile infection (adjunctive use)

Clinical studies suggest that Lactobacillus may reduce the duration of acute diarrhea by approximately one day when administered early during the illness.

Adverse Effects

Most patients tolerate Lactobacillus very well.

Occasional adverse effects include:

• Flatulence
• Mild abdominal discomfort
• Bloating

Serious bloodstream infections are extremely rare but may occur in severely immunocompromised patients.

Contraindications

Use with caution in:

• Severely immunocompromised patients
• Patients with central venous catheters
• Critically ill individuals
• Patients with severe neutropenia

---

Saccharomyces boulardii

Saccharomyces boulardii is a non-pathogenic yeast probiotic that has demonstrated effectiveness in several diarrheal disorders. Unlike bacterial probiotics, it is not destroyed by antibacterial antibiotics, making it particularly useful during antibiotic therapy.

Mechanism of Action

Its beneficial effects include:

• Neutralization of bacterial toxins
• Inhibition of pathogen adhesion
• Enhancement of intestinal immune responses
• Preservation of intestinal barrier integrity
• Reduction of inflammation
• Restoration of microbial balance

Therapeutic Uses

Saccharomyces boulardii is indicated for:

• Antibiotic-associated diarrhea
• Prevention of recurrent Clostridioides difficile infection
• Traveler's diarrhea
• Acute infectious diarrhea
• Persistent diarrhea in selected patients

Adverse Effects

The medication is generally well tolerated.

Reported adverse effects include:

• Flatulence
• Mild constipation
• Abdominal bloating
• Nausea

Rarely, fungemia has been reported in severely immunocompromised patients or individuals with central venous catheters.

Contraindications

It should be avoided in:

• Patients with severe immunodeficiency
• Critically ill patients
• Patients with central venous catheters
• Individuals with known yeast allergy

When appropriately selected, probiotics can be valuable adjuncts in the management of diarrhea, especially in reducing the duration of illness and preventing antibiotic-associated gastrointestinal complications.